This news is delayed by 15 minutes, sign up now to get live news & full features.
GLPG GALAPAGOS NV
+ add to watchlist
$29.42
Galapagos NV is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action.
Mkt Cap: $1.94B
52 Week High: $37.78
P/E: 0.00
52 Week Low: $22.59
Dividend: $0.00
Shares Outstanding: 65.9M